Moreover, targeting NRF2 can upregulate PHKG2, promote ferritin phagocytosis, enhance radiation-induced mitochondrial dysfunction, thereby increasing the sensitivity of NSCLC to radiation therapy (Fig. 7). The gene discussed is NFE2L2; the disease is non-small cell lung carcinoma.